Sort
261,768 grants matching “gene therapy”
Modeling Disease in Swine by Transplantation of Gene Targeted Germ Cells
$986,749Daniel Fred Carlson · Recombinetics, Inc. · R44 · FY2018 · GM
Screening for rAAV transduction enhancers
$986,692Terry L Bowlin · Microbiotix, Inc · R44 · FY2022 · AI
Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines
$986,671Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2021 · AI
A human cytomegalovirus-based immunotherapy for HIV-1
$986,519Eric Bruening · Tomegavax, Inc. · R44 · FY2015 · AI
Human Connectomes for Low Vision, Blindness, and Sight Restoration
$986,513Yonggang Shi · University Of Southern California · U01 · FY2018 · EY
Gene Expression Profiling/Chronic Lymphocytic Leukemia
$986,494Adrian U Wiestner · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Genome instability in cancer: telomeres and DNA repair
$986,492Titia De Lange · Rockefeller University · R35 · FY2019 · CA
Phosphoinositides and Cancer Metabolism
$986,489Lewis C Cantley · Weill Medical Coll Of Cornell Univ · R35 · FY2019 · CA
MODEL SYSTEMS TOWARD DEVELOPMENT OF HUMAN GENE THERAPY
$986,451University Of Pittsburgh At Pittsburgh · P01 · FY2001 · DK
rhMFG-E8 as an Effective Adjuvant Therapy for Hemorrhagic Shock
$986,433Max Brenner · Therasource, Llc · R44 · FY2021 · HL
Diet, Activity, and Lifestyle as a Risk Factor for Colorectal Cancer
$986,392Martha Or Marty L Slattery · University Of Utah · R01 · FY2012 · CA
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models
$986,350Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$986,350Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Molecular profile of proviral reservoirs in HIV-infected drug users
$986,339Xu Yu · Massachusetts General Hospital · R33 · FY2022 · DA
Prophylactic Immunotherapy for Marburg Virus Disease Outbreak Control
$986,248M. Javad Aman · Abvacc, Inc. · R44 · FY2023 · AI
Identification of Novel Mutations In Pediatric Cancers
$986,235Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance
$986,128Bryan E. Welm · University Of Utah · U01 · FY2020 · CA
Dual-targeting allogeneic CAR T-cells for universal therapy of T-cell malignancies
$986,080Sarah Marie Hein · March Biosciences Inc · R44 · FY2025 · CA
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
$986,054Justin Kawika Ichida · University Of Southern California · R01 · FY2024 · NS
Studies of the Natural History of Sickle Cell Disease
$986,035Swee Lay Thein · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Interdepartmental Biotechnology Training Program
$985,975Massachusetts Institute Of Technology · T32 · FY2004 · GM
Advanced Prodrug Treatment for CML
$985,960Milton H. Werner · Inhibikase Therapeutics · R44 · FY2019 · CA
Expanding insights into FTD disease mechanisms
$985,949Leonard Petrucelli · Mayo Clinic Jacksonville · R35 · FY2024 · NS
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$985,870Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Molecular mechanism of TNF signaling and apoptosis
$985,827Zheng-Gang Liu · Clinical Sciences · Z01 · FY2007 · CA